Run faster
11 October 2016
Email
Share
That’s one way to view Illumina’s sales shock, which singed $7 bln of investor wealth. Machines for mapping out human genomes are improving faster than researchers can figure out how to use them. For buyers with ideas on how to push testing in clinics this creates opportunity.
This content is for Subscribers only
To access full Breakingviews.com content you must be a subscriber. Please use the following link to request a trial.